Table 1.
Clinical Characteristics of Breast Cancer Patients
| Clinicopathological Data | n | Percentage (%) |
|---|---|---|
| Age (years) | ||
| ≤50 | 18 | 69.2 |
| >50 | 8 | 30.8 |
| Primary tumor size (cm) | ||
| ≤5 | 16 | 61.5 |
| >5 | 10 | 38.5 |
| Lymph node metastasis | ||
| Present | 21 | 80.8 |
| Absent | 5 | 19.2 |
| TNM stage | ||
| I–II | 11 | 42.3 |
| III–IV | 15 | 57.7 |
| Histopathological grade | ||
| I–II | 15 | 57.7 |
| III | 11 | 42.3 |
| ER status | ||
| Positive | 13 | 50.0 |
| Negative | 13 | 50.0 |
| PR status | ||
| Positive | 11 | 42.3 |
| Negative | 15 | 57.7 |
| HER-2 status | ||
| Positive | 12 | 46.2 |
| Negative | 14 | 53.8 |
| Molecular subtype | ||
| Luminal A | 5 | 19.2 |
| Luminal B | 9 | 34.6 |
| Her-2 overexpressing | 8 | 30.8 |
| Triple negative | 4 | 15.4 |
TNM, tumor, node, metastasis; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor-2.